Isocitrate Dehydrogenase 1 (IDH1) Mutation-Specific microRNA Signature Predicts Favorable Prognosis in Glioblastoma Patients With IDH1 Wild Type

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/1756-9966-32-59
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

2-Hydroxyglutarate (2-Hg); Isocitrate Dehydrogenase 1 (IDH1)

Science-Business eXchange
2013English

Correlation of IDH1 Mutation With Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients From China

PLoS ONE
Multidisciplinary
2012English

IDH1-Wild-type Gliomas Are Dependent on BCAT1

Cancer Discovery
Oncology
2013English

Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated With Malignant Progression but Predicted Longer Survival

PLoS ONE
Multidisciplinary
2013English

IDH1 Mutation in Gliomas in Mosul City - Iraq

Open Access Macedonian Journal of Medical Sciences
Medicine
2015English

Overexpression of PSAT1 Gene Is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients With IDH1 Mutations and Chromosome 1p19q Codeletion

Cancers
Cancer ResearchOncology
2019English

Mutant IDH1 and Seizures in Patients With Glioma

Neurology
Neurology
2017English

IDH1 Mutation Diminishes Aggressive Phenotype in Glioma Stem Cells

International Journal of Oncology
Cancer ResearchOncology
2017English

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy